Aurore Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for An integrated company with complete control of key starting materials, advanced intermediates & high-quality APIs.
One of their notable products is CELECOXIB USP, with a corresponding US DMF Number 34070.
Remarkably, this DMF maintains an Active status since its submission on August 08, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2021, and payment made on December 04, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II